Newsroom | 1316 results

MEXICO CITY & MIAMI & SÃO PAULO--(BUSINESS WIRE)--The AIDS Healthcare Foundation (AHF) and the AHF Global Public Health Institute acknowledge the conclusion of three years of negotiations on the global pandemic agreement text by congratulating the negotiators—particularly representatives of the Equity and Africa Groups—and recognizing the contributions of key stakeholders, including civil society, who championed equitable access to public health goods. “Even before the COVID-19 pandemic, we beg...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The life sciences innovation ecosystem continued to evolve and expand in 2024 as the industry continued to adapt to a complex and dynamic range of geopolitical, technological and social uncertainties. The year saw progress in funding, trial starts, program productivity and cycle times, according to the new report, Global Trends in R&D 2025: Progress in Recapturing Innovation in Biopharma Innovation, released by the IQVIA Institute for Human Dat...

LONDON--(BUSINESS WIRE)--This year, International SOS marks its 40th anniversary, reflecting on 4 decades of safeguarding the health, security & wellbeing of clients worldwide...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2025 financial results and guidance will be released on Thursday, April 24, 2025 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s first quarter 2025 financial results and provide a business update. A live webcast will be available in the Investors section of www.gilead.com and will be archived there for one...

BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing treatments and diagnostic tools for global public health and zoonosis concerns, will present new data from universal influenza pipeline candidates during two poster sessions at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2025. Longhorn will also be available at booth C108 in Hall B to discuss its differentiated approach to the...

GOLDEN, Colo.--(BUSINESS WIRE)--Published analysis showed the GEMCOVAC-OM COVID-19 booster administered exclusively with Tropis ID induced a broad and long-lasting immune response....

SYDNEY--(BUSINESS WIRE)--Novotech Report Reveals Global Surge in Infectious Disease Trials as Industry Nears 2,000 Studies Since 2020...

雪梨--(BUSINESS WIRE)--(美國商業資訊)-- Novotech作為一家可提供全方位服務的國際性受託研究機構 (CRO) 和科學諮詢公司，致力於攜手生物科技公司以及中小型製藥公司，共同推動藥物開發。近日，Novotech發佈了一份新報告，分析了不斷變化的傳染病臨床試驗領域。本報告為2025年在全球傳染病研發領域的複雜環境中摸索前行的製藥和生物科技公司提供了關鍵策略洞察。 探索傳染病臨床試驗的未來 2020年至2024年間，全球傳染病臨床試驗顯著成長，已經啟動、展開或規劃的臨床試驗近2000項。在政府的大力支持和國際合作的推動下，亞太地區在這一擴張趨勢中佔據重要地位，年複合成長率 (CAGR) 高達70%。其次是北美地區，CAGR達到52%，主要得益於生物科技領域巨額投資的持續湧入。歐洲及全球其他地區的臨床試驗則穩定成長，這種趨勢不僅促進了全球臨床研究的地域多樣性，也增強了臨床試驗體系的穩健性。 主要發現： 全球臨床試驗成長：在全球傳染病臨床試驗版圖中，亞太地區占有比例較高，達43%，其次是北美 (21%)、歐洲 (20%) 以及世界其他地區 (16%)。 重點治療領域：...

悉尼--(BUSINESS WIRE)--(美国商业资讯)-- Novotech（诺为泰）作为一家可提供全方位服务的国际性临床研究组织 (CRO) 和科学咨询公司，致力于携手生物科技公司以及中小型制药公司，共同推进药物开发。近日，诺为泰发布了一份新报告，分析了不断演变的传染病临床试验格局。本报告为2025年在全球传染病研发领域的复杂环境中摸索前行的制药和生物科技公司提供了关键战略洞察。 探索传染病临床试验的未来 2020年至2024年间，全球传染病临床试验显著增长，已经启动、开展或规划的临床试验近2000项。在政府的大力支持和国际合作的推动下，亚太地区在这一扩张趋势中占据重要地位，复合年增长率 (CAGR) 高达70%。其次是北美地区，CAGR达到52%，主要得益于生物科技领域巨额投资的持续涌入。欧洲及全球其他地区的临床试验稳步推进，这种趋势不仅促进了全球临床研究的地域多样性，也增强了临床试验体系的稳健性。 主要发现： 全球临床试验增长：在全球传染病临床试验版图中，亚太地区占比较高，达43%，其次是北美 (21%)、欧洲 (20%) 以及世界其他地区 (16%)。 重点治疗领域：传染病...

DALLAS--(BUSINESS WIRE)--A new brief report published in the American Journal of Infection Control (AJIC) demonstrates that ActivePure’s Advanced Photohydrolysis (AP) Technology effectively and rapidly inactivates aerosolized SARS-CoV-2, respiratory syncytial virus (RSV), and monkeypox virus (MPXV). The study highlights AP’s potential as a valuable tool for improving indoor air quality and infection control, particularly in high-risk settings. About the Study: The study, which was designed and...